Since retatrutide has no FDA approval, there is no legal basis for compounding it
10.2147/DDDT.S82030 47 IlicS.BrcicI.MesterM.FilipovicM.SeverM.KlicekR.et al (2009)
A., Gasis, M., Thorens, B., Mller, H
site rotation ensures that compound works consistently and comfortably throughout your treatment journey
Hypersensitivity Reactions In a pool of Study 1 and 2, immediate hypersensitivity reactions (within one day after drug administration) occurred in 2.1% of ZEPBOUND-treated patients compared to 0.4% of placebo-treated patients, while non-immediate hypersensitivity reactions occurred in 3.5% of ZEPBOUND-treated patients compared to 2.7% of placebo-treated patients
If youve been trying to manage your weight through diet and exercise but the results arent quite what youve been hoping for, it may be time to try a new tool